2-185738775-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NR_110217.1(FSIP2-AS2):n.99+1604C>T variant causes a intron, non coding transcript change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000289 in 1,383,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NR_110217.1 intron, non_coding_transcript
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSIP2-AS2 | NR_110217.1 | n.99+1604C>T | intron_variant, non_coding_transcript_variant | |||||
FSIP2 | NM_173651.4 | upstream_gene_variant | ENST00000424728.6 | NP_775922.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSIP2-AS2 | ENST00000427269.2 | n.101+1604C>T | intron_variant, non_coding_transcript_variant | 5 | ||||||
FSIP2-AS1 | ENST00000667756.1 | n.37+49991C>T | intron_variant, non_coding_transcript_variant | |||||||
FSIP2-AS2 | ENST00000437717.1 | n.119+132C>T | intron_variant, non_coding_transcript_variant | 3 | ||||||
FSIP2 | ENST00000424728.6 | upstream_gene_variant | 5 | NM_173651.4 | ENSP00000401306 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000289 AC: 4AN: 1383660Hom.: 0 Cov.: 31 AF XY: 0.00000146 AC XY: 1AN XY: 682788
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.148G>A (p.G50S) alteration is located in exon 1 (coding exon 1) of the FSIP2 gene. This alteration results from a G to A substitution at nucleotide position 148, causing the glycine (G) at amino acid position 50 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.